Company / Operating Income
PUMA BIOTECHNOLOGY, INC. Operating Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$32.6M
FY2025
5-year range
-$39.0M / $32.6M
FY2021-FY2025
Trend
+37.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has increased for 6 consecutive years, from -$292M in FY2019 to $33M in FY2025.
Based on SEC 10-K filings.
$33M in FY2025.
Improved from $1M to $33M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- PUMA BIOTECHNOLOGY, INC.'s operating income has grown for 6 consecutive years.
- In FY2025, operating income increased 37.6% year-over-year.
- Lowest operating income in the period was in FY2019.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.6M | +37.6% |
| FY2024 | $23.7M | +1738.8% |
| FY2023 | $1.3M | +104.2% |
| FY2022 | -$30.4M | +22.1% |
| FY2021 | -$39.0M | +58.8% |
| FY2020 | -$94.7M | +67.6% |
| FY2019 | -$292.4M | -5.7% |
| FY2018 | -$276.6M | -15.1% |
| FY2017 | -$240.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026